These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 16087334
1. Novel inhibitors of the hepatitis C virus NS3 proteinase. Bennett F, Liu YT, Saksena AK, Arasappan A, Butkiewicz N, Dasmahapatra B, Pichardo JS, Njoroge FG, Patel NM, Huang Y, Yang X. Bioorg Med Chem Lett; 2005 Oct 01; 15(19):4275-8. PubMed ID: 16087334 [Abstract] [Full Text] [Related]
4. Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles. Chen KX, Njoroge FG, Arasappan A, Venkatraman S, Vibulbhan B, Yang W, Parekh TN, Pichardo J, Prongay A, Cheng KC, Butkiewicz N, Yao N, Madison V, Girijavallabhan V. J Med Chem; 2006 Feb 09; 49(3):995-1005. PubMed ID: 16451065 [Abstract] [Full Text] [Related]
5. P2-P4 macrocyclic inhibitors of hepatitis C virus NS3-4A serine protease. Arasappan A, Njoroge FG, Chen KX, Venkatraman S, Parekh TN, Gu H, Pichardo J, Butkiewicz N, Prongay A, Madison V, Girijavallabhan V. Bioorg Med Chem Lett; 2006 Aug 01; 16(15):3960-5. PubMed ID: 16730985 [Abstract] [Full Text] [Related]
8. The N-terminal region of NS3 serine proteinase of hepatitis C virus is important to maintain its enzymatic integrity. Mori A, Yuasa S, Yamada K, Nagami Y, Miyamura T. Biochem Biophys Res Commun; 1997 Feb 24; 231(3):738-42. PubMed ID: 9070884 [Abstract] [Full Text] [Related]
12. Second-generation highly potent and selective inhibitors of the hepatitis C virus NS3 serine protease. Chen KX, Nair L, Vibulbhan B, Yang W, Arasappan A, Bogen SL, Venkatraman S, Bennett F, Pan W, Blackman ML, Padilla AI, Prongay A, Cheng KC, Tong X, Shih NY, Njoroge FG. J Med Chem; 2009 Mar 12; 52(5):1370-9. PubMed ID: 19196021 [Abstract] [Full Text] [Related]
13. Novel 2-oxoimidazolidine-4-carboxylic acid derivatives as hepatitis C virus NS3-4A serine protease inhibitors: synthesis, activity, and X-ray crystal structure of an enzyme inhibitor complex. Arasappan A, Njoroge FG, Parekh TN, Yang X, Pichardo J, Butkiewicz N, Prongay A, Yao N, Girijavallabhan V. Bioorg Med Chem Lett; 2004 Dec 06; 14(23):5751-5. PubMed ID: 15501035 [Abstract] [Full Text] [Related]
14. Phosphorous acid analogs of novel P2-P4 macrocycles as inhibitors of HCV-NS3 protease. Pompei M, Francesco ME, Koch U, Liverton NJ, Summa V. Bioorg Med Chem Lett; 2009 May 01; 19(9):2574-8. PubMed ID: 19328685 [Abstract] [Full Text] [Related]
15. Synthesis and antiviral evaluation of a novel series of homoserine-based inhibitors of the hepatitis C virus NS3/4A serine protease. Alexandre FR, Brandt G, Caillet C, Chaves D, Convard T, Derock M, Gloux D, Griffon Y, Lallos L, Leroy F, Liuzzi M, Loi AG, Moulat L, Musiu C, Parsy C, Rahali H, Roques V, Seifer M, Standring D, Surleraux D. Bioorg Med Chem Lett; 2015 Sep 15; 25(18):3984-91. PubMed ID: 26231161 [Abstract] [Full Text] [Related]